Friso Schlottau of Covidien in the U.S. will develop a durable device that can measure heart and respiration rates and blood oxygen levels in people of all ages, including newborns, in low-resource settings. They will build a prototype device that can be charged like a mobile phone, incorporating adapted algorithms and a robust multi-patient sensor that can withstand extended periods of use. The device will be bench tested by simulating the range of sick and healthy patients to ensure it is functional under different conditions. They will also test its accuracy by using it on ten healthy volunteers.
More information about New Ways to Reduce Pneumonia Fatalities Through Timely, Effective Treatment of Children (Round 14)